Elevated plasminogen activator inhibitor-1 (PAI-1) activity has been hypothesized as one of the major causes for COVID-19 associated fibrinolysis resistance and fibrinolysis shutdown in COVID-19 patients [29]. This evidence concerns the gene SERPINE1 and COVID-19.